| Website | oxbio.com |
| Phone | (617) 357-7474 |
| Employees | |
| Founded | 1992 |
| Fund VI, 1/11 | $66M |
Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stage situations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.
| Company | Date | Round | Size | Participants |
| Mitralign | 5/12 | Series D | $35M | 6 |
| Glori Energy | 1/12 | Series C | $20M | 6 |
| CardioFocus | 2/11 | Series C | $30.6M | 9 |
| SuperDimension | 9/10 | Venture Round | $24.8M | 4 |
| Tragara | 4/10 | Series B | $5M | 5 |
| Seahorse Bioscience | 3/10 | Series D | $5M | 7 |
| Molecular Biometrics | 1/10 | Series B | $12.5M | 3 |
| CircuLite | 1/10 | Series C | $32.5M | 4 |
| Cambrios Technologies | 11/09 | Series D | $14.5M | 14 |
| Coherex Medical | 10/09 | Series B | $16.5M | 3 |
| VaxInnate | 6/09 | Series D | $30M | 7 |
| Elixir Pharmaceuticals | 5/09 | Series D | $12M | 5 |
| Claros Diagnostics | 3/09 | Series B | $4M | 4 |
| Seahorse Bioscience | 3/09 | Series D | $6M | 7 |
| Pathway Medical Technologies | 3/09 | Series D | $42.5M | 5 |
| Rib-X Pharmaceuticals | 1/09 | Venture Round | $25M | 8 |
| Luca Technologies | 12/08 | Series C | $75.9M | 3 |
| Radius Health | 11/08 | Series C | $15M | 6 |
| BrainCells | 3/08 | Series B | $30M | 6 |
| Laboratory Partners | 1/08 | Series D | $16M | 3 |
| Luca Technologies | 10/07 | Series B | $20M | 3 |
| Intechra Holdings | 5/07 | Series C | $30M | 5 |
| Radius Health | 4/07 | Series B | $57.5M | 6 |
| Elixir Pharmaceuticals | 11/06 | Series C | $46M | 6 |
| Solstice Neurosciences | 11/06 | Series B | $85M | 5 |
| VaxInnate | 10/06 | Series C | $40M | 6 |
| FlowMedica | 11/05 | Series D | $15M | 5 |
| Solstice Neurosciences | 7/05 | Venture Round | $8M | 4 |
| Cambrios Technologies | 2/05 | Series B | $12M | 8 |
| Ensemble Discovery | 5/04 | Series A | $15M | 3 |